FC600 Compact Recirculating Cooler
JULABO GmbHModels for heating and cooling applications, up to 2.5 kW cooling capacity
Models for heating and cooling applications, up to 2.5 kW cooling capacity
Models for heating and cooling applications, up to 2.5 kW cooling capacity
The new XIENCE Skypoint stent received FDA approval in the U.S. and CE Mark approval in Europe
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour
The approach lays the foundation for novel ways to map connections across different brain regions
Detection to trace levels of some metabolites, such as histamine, some amino acids, some steroids and catecholamines, is quickly and simply achieved, with Cecil Electrochemical Detection Adept HPLC.
Recirculating Cooler/Chiller for environmentally friendly cooling
Recirculating Cooler/Chiller for environmentally friendly cooling
Recirculating Cooler/Chiller for environmentally friendly cooling
New, easy-to-use analytical systems provide high-throughput comprehensive characterization and quantitation of small and large molecules
Pkg of 1, kit includes the necessary tubing, fittings, and a sample injection port, for automated application of small sample volume samples
Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data
Scientists propose gene editing to restore lost genetic diversity and rescue endangered species, combining modern biotech with traditional conservation
Learn how one scientist is harnessing the latest imaging technology to advance his research and generate high-resolution images of neural tissue
See how high-resolution multiplex immunofluorescence imaging can elucidate the important role the immune system plays in health, disease, and drug development
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years